Edwards Lifesciences CorporationEWNYSE
Loading
Cash Flow PerformanceElevated
Percentile Rank71
3Y CAGR+9.1%
5Y CAGR+18.6%
Year-over-Year Change
Free cash flow yield
3Y CAGR
+9.1%/yr
vs -0.9%/yr prior
5Y CAGR
+18.6%/yr
Recent deceleration
Acceleration
+9.9pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.68% | +308.7% |
| 2024 | 0.66% | -51.9% |
| 2023 | 1.36% | -34.1% |
| 2022 | 2.06% | +18.9% |
| 2021 | 1.74% | +52.5% |
| 2020 | 1.14% | -38.6% |
| 2019 | 1.85% | -13.3% |
| 2018 | 2.14% | -38.4% |
| 2017 | 3.47% | +42.3% |
| 2016 | 2.44% | - |